Choi, M.J.; Lee, Y.K.; Choi, K.C.; Lee, D.H.; Jeong, H.Y.; Kang, S.J.; Kim, M.W.; You, Y.M.; Im, C.S.; Lee, T.S.;
et al. Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer. Pharmaceutics 2023, 15, 350.
https://doi.org/10.3390/pharmaceutics15020350
AMA Style
Choi MJ, Lee YK, Choi KC, Lee DH, Jeong HY, Kang SJ, Kim MW, You YM, Im CS, Lee TS,
et al. Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer. Pharmaceutics. 2023; 15(2):350.
https://doi.org/10.3390/pharmaceutics15020350
Chicago/Turabian Style
Choi, Moon Jung, Yeon Kyung Lee, Kang Chan Choi, Do Hyun Lee, Hwa Yeon Jeong, Seong Jae Kang, Min Woo Kim, Young Myoung You, Chan Su Im, Tae Sup Lee,
and et al. 2023. "Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer" Pharmaceutics 15, no. 2: 350.
https://doi.org/10.3390/pharmaceutics15020350
APA Style
Choi, M. J., Lee, Y. K., Choi, K. C., Lee, D. H., Jeong, H. Y., Kang, S. J., Kim, M. W., You, Y. M., Im, C. S., Lee, T. S., & Park, Y. S.
(2023). Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer. Pharmaceutics, 15(2), 350.
https://doi.org/10.3390/pharmaceutics15020350